ADVB — Advanced Biomed Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1941029 ·
Last close
$6.73
Market Cap
$11.12M
52W High
$24.23
52W Low
$3.61
ADV30
144,303
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -519,836 | -488,942 | 10,646,324 | 2,602,697 | 1,436,587 |
| Dec 2025 | 0 | — | -396,642 | 6,857,921 | 10,850,712 | 2,604,666 | 1,369,070 |
| Sep 2025 | 0 | — | -523,914 | -386,901 | 6,242,970 | 2,656,519 | 3,238,846 |
| Mar 2025 | 0 | — | -762,739 | -1,383,874 | 8,287,598 | 5,184,100 | 4,157,815 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,923,688
Investing CF
$-18,156
Financing CF
$6,283,695
CapEx
$-18,156
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$4.07
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-13,250,966
Inventory
$8,835
Receivables
$5,981,742
ST Investments
—
EBIT TTM
$-1,976,893
Pretax Income TTM
$4,928,836
Interest Exp TTM
$112
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2025 | — | — | — | — | — | — | — |
| Jun 2024 | 0 | -2,541,572 | -2,782,278 | 4,460,247 | 2,796,989 | 1,663,258 | -2,126,340 |
| Jun 2023 | 0 | -3,071,223 | -3,732,777 | 4,599,977 | 3,294,389 | 1,305,588 | -2,963,625 |
| Jun 2022 | 0 | -2,374,371 | -4,027,722 | 6,713,499 | 3,221,903 | 3,491,596 | -741,450 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CCM | Concord Medical Services Holdings Ltd | $9.97M | $3.54 | — |
| PFHO | PACIFIC HEALTH CARE ORGANIZATION INC | $12.80M | $1.00 | — |
| AMS | AMERICAN SHARED HOSPITAL SERVICES | $9.51M | $1.43 | — |
| XCRT | Xcelerate, Inc. | $8.69M | $0.02 | — |
| MGRX | MANGOCEUTICALS, INC. | $8.30M | $0.38 | — |
News headlines (Yahoo Finance, 1h cache)
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
2026-02-18 12:00 · Yahoo
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
2026-02-13 13:00 · Yahoo
Advanced Biomed sells Hong Kong subsidiary for $23,000
2025-12-31 15:25 · Yahoo
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
2025-12-30 15:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.